Journal of Developing Drugs
Open Access

Joint Event on 8^th International Conference and Exhibition on Pharmaceutical Regulatory Affairs and IPR & 8^th International Conference and Exhibition on Pharma Audit, GMP, GCP & Quality Control

June 08-09, 2018 | Philadelphia, USA

Posters & Accepted Abstracts

• The efficiency of inefficiency: Medicine distribution in Sudan

  Abdeen Mustafa Omer

  PDF HTML

• Best industry practices: Optimizing dairy food processing

  Adenle Bamidele Johnson

  PDF HTML

• Green tea polyphenols for the protection against isoprenaline-induced myocardial infarction in experimental hyperhomocysteinemia rats

  Azza Hafiz EL Medany and Jamila Hafiz El Medany

  PDF HTML

• Esculentoside B (ESB) in anti-inflammatory responses and cellular roles of ganglioside GM3 biosynthesis in human cancer cells

  Cheorl-Ho Kim, HakSeong Lim, Fukushi Abekura, Jun-Young Park, Sun-Hyung Ha, Hyunju Choi and Kyongho Lee

  PDF HTML

• Navigating the Canadian drug establishment licensing system

  Doreen Clark Steen

  PDF HTML

• Magnesium in the internal environment

  Anil Batta

  PDF HTML

• Pharmacokinetic study of anti-histaminic activity of formulated nano-gel/emulgel and conventional intranasal drug delivery of diphenhydramine HCl by HPLC method

  Hina Javed

  PDF HTML

• Ascofuranone inhibits lipopolysaccharide-induced inflammatory response via NF-kappaB and AP-1, p-ERK, TNF-α, IL-6 and IL-1β in RAW 264.7 macrophages

  Hak Seong Lim, Sun-Hyung Ha, Jun young Park, Fukushi Abekura and Cheorl-Ho Kim

  PDF HTML

• Regulatory affairs–pharmacovigilance: Collaborative channel

  Harikesh Kalonia

  PDF HTML

• Development and validation of extraction procedures and quantitative determination methods of natural colorants obtained from agro-industrial waste materials using stepwise extraction techniques and high performance liqu

  Imeda Rubashvili, Mzia Tsitsagi and Ketevan Ebralidze

  PDF HTML

• Maximizing the impact of strong compliance audits

  Jennifer Lopez

  PDF HTML

• Regulatory framework and requirements for orphan drug designation and development programs

  Jessica Elizabeth Foley

  PDF HTML

• An overview of expedited drug regulatory pathways

  Jessica Elizabeth Foley

  PDF HTML

• Same and different: Version 4 of the eCTD standard

  Joel Finkle

  PDF HTML

• AS-6 suppresses lipopolysaccharide–induced neuroinflammation in BV2 microglial cells via inhibition of NF-κB and MAPK pathway

  Jun Young Park, Sun-Hyung Ha, Fukushi Abekura, Hak Seong Lim and Cheorl-Ho Kim

  PDF HTML

• High performance liquid chromatography as acceptance criteria in antiviral capsules

  Luis Cruz Rodriguez

  PDF HTML

• Method determination of doses to for prolonging the life of local therapists

  Tsabang Nole

  PDF HTML

• The impact of the global regulatory agencies expectations and its impact on small and medium business units of Indian pharmaceutical industrial progress and the role of software in reaching the global regulatory expectat

  Sagaram Sudhakar and S.V.S.L.Sujatha

  PDF HTML

• A hurdle too high? The challenges of managing regulatory and quality systems for cGMP within small businesses

  Thomas Biere

  PDF HTML

• Good supply practices: Why are we still vulnerable?

  Troy Fugate

  PDF HTML

• Crisis of quality management

  Raminder Pal Singh

  PDF HTML